Navigator Medicines logo

Navigator Medicines

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$100M


Navigator Medicines develops biologics for targeted immune regulation and restoration, focusing on OX40L-targeted mono- and bispecific antibodies.

Total Funding

$100M

Headquarters

Scotch Plains, USA

Founded

2024

Focus Areas

biotech
bispecific antibodies
immune regulation
biologics
OX40L-targeted therapies

Investors

RA Capital Management logo
Forbion logo